Abstract | BACKGROUND: Uncooked corn- starch (UCCS) has been the mainstay of therapy for the hepatic glycogen storage diseases (GSD) but is not always effective. A new starch (WMHMS) has demonstrated a more favourable short-term metabolic profile. OBJECTIVE: To determine efficacy and safety of a new uncooked starch (WMHMS) compared to UCCS over 16 weeks treatment with each. METHOD: A double-blind cross-over study of 10 adults (aged 16 - 38 years, six male) with GSD Ia and Ib. After an individualised fast, subjects were randomised to take a 50 g starch-load of either WMHMS or UCCS. Starch-loads terminated when blood glucose was < 3.0 mmol/L or the subject felt subjectively hypoglycaemic. Anonymous biochemical profiles were assessed by 2 investigators and a starch administration schedule recommended. Each starch was delivered in coded sachets and intake was monitored for the following 16 weeks. After a washout period, the protocol was repeated with the alternative product. RESULTS: 4 subjects failed to establish therapy on the cross-over limb. Data from 7 paired starch load showed: longer median fasting duration with WMHMS (7.5 versus 5 hours; p = 0.023), slower decrease in the glucose curve (0.357 versus 0.632 mmol/hr p = 0.028) and less area under insulin curves for the first 4 hours (p = 0.03). Two of six subjects took 50% or less WMHMS compared to UCCS and one took more. Plasma triglycerides, cholesterol and uric acid were unchanged after each study phase. CONCLUSION: WMHMS leads to significant reduction in insulin release and reduced starch use in some GSD patients.
|
Authors | Kaustuv Bhattacharya, Helen Mundy, Maggie F Lilburn, Michael P Champion, David W Morley, François Maillot |
Journal | Orphanet journal of rare diseases
(Orphanet J Rare Dis)
Vol. 10
Pg. 18
(Feb 15 2015)
ISSN: 1750-1172 [Electronic] England |
PMID | 25758258
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
|
Topics |
- Adolescent
- Adult
- Blood Glucose
(drug effects)
- Cross-Over Studies
- Double-Blind Method
- Female
- Glycogen Storage Disease Type I
(diet therapy)
- Humans
- Male
- Pilot Projects
- Starch
(chemistry, pharmacology)
- Young Adult
|